Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice

Cited by (460)

Items 101–200 of 460

  1. 670 nm Laser Light and EGCG Complementarily Reduce Amyloid-β Aggregates in Human Neuroblastoma Cells: Basis for Treatment of Alzheimer's Disease?
    Andrei P. Sommer, Jan Bieschke, Ralf P. Friedrich, Dan Zhu, Erich E. Wanker, H.‐J. Fecht, Derliz Mereles, WERNER HUNSTEIN · 2011 · Photomedicine and Laser Surgery
  2. The protective role of plant biophenols in mechanisms of Alzheimer's disease
    Syed Haris Omar, Christopher Scott, Adam S. Hamlin, Hassan K. Obied · 2017 · The Journal of Nutritional Biochemistry
  3. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
    Javed Ahmad, Sohail Akhter, Md. Rizwanullah, Mohammad Ahmed Khan, Lucie Pigeon, Richard T. Addo, Nigel H. Greig, Patrick Midoux, Chantal Pichon, Mohammad Amjad Kamal · 2017 · Current Alzheimer Research
  4. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats
    Shanji Nan, Peng Wang, Yizhi Zhang, Jia Fan · 2021 · Drug Design Development and Therapy
  5. Black tea in chemo-prevention of cancer and other human diseases
    Min‐Hsiung Pan, Ching‐Shu Lai, Hong Wang, Chih‐Yu Lo, Chi‐Tang Ho, Shiming Li · 2013 · Food Science and Human Wellness
  6. Crystal Engineering of Green Tea Epigallocatechin-3-gallate (EGCg) Cocrystals and Pharmacokinetic Modulation in Rats
    Adam J. Smith, P. Kavuru, Kapildev K. Arora, Sheshanka Kesani, Jun Tan, Michael John Zaworotko, R. Douglas Shytle · 2013 · Molecular Pharmaceutics
  7. The Effect of (−)-Epigallo-catechin-(3)-gallate on Amyloidogenic Proteins Suggests a Common Mechanism
    Kathrin Andrich, Jan Bieschke · 2015 · Advances in experimental medicine and biology
  8. Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities
    Orly Weinreb, Tamar Amit, Silvia A. Mandel, Lana Kupershmidt, Moussa B. H. Youdim · 2010 · Antioxidants and Redox Signaling
  9. Potential therapeutic agents against Alzheimer’s disease from natural sources
    So‐Young Park · 2010 · Archives of Pharmacal Research
  10. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
    Dagmar E. Ehrnhoefer, Bibiana K. Y. Wong, Michael R. Hayden · 2011 · Nature Reviews Drug Discovery
  11. EGCG-mediated autophagy flux has a neuroprotection effect via a class III histone deacetylase in primary neuron cells
    Ju‐Hee Lee, Ji-Hong Moon, Sung-Wook Kim, Jae‐Kyo Jeong, Uddin Md. Nazim, You-Jin Lee, Jae‐Won Seol, Sang‐Youel Park · 2015 · Oncotarget
  12. Modulating Self‐Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and Mechanisms
    Ting‐Yu Liu, Gal Bitan · 2012 · ChemMedChem
  13. Potential Role of (-)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease
    Laura Xicota, José Rodríguez-Morató, Mara Dierssen, Rafael de la Torre · 2015 · Current Drug Targets
  14. Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action
    Katriona L. Hole, Robert J. Williams · 2020 · Brain Plasticity
  15. The Pharmacological Activity of Epigallocatechin-3-Gallate (EGCG) on Alzheimer's Disease Animal Model: A Systematic Review
    Zhang, Shuang, Zhu, Qi, Chen, Jia-Yue, OuYang, Defang, Lu, Jia-Hong · 2020 · Phytomedicine
  16. Current perspectives on pharmacotherapy of Alzheimer's disease
    Kanwaljit Chopra, Shubham Misra, Anurag Kuhad · 2011 · Expert Opinion on Pharmacotherapy
  17. Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
    Ryuuta Fukutomi, Tomokazu Ohishi, Yu Koyama, Monira Pervin, Yoriyuki Nakamura, Mamoru Isemura · 2021 · Molecules
  18. Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
    Kumju Youn, Chi‐Tang Ho, Mira Jun · 2022 · Food Science and Human Wellness
  19. Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
    Julia E. Gerson, Diana Laura Castillo‐Carranza, Rakez Kayed · 2014 · ACS Chemical Neuroscience
  20. Neuroprotective Potential of Flavonoids in Brain Disorders
    Syed Hasan, Nabeel Khatri, Zainab N. Rahman, Amanda A. Menezes, Joud Martini, Faheem Shehjar, Numa Mujeeb, Zahoor Ahmad Shah · 2023 · Brain Sciences
  21. Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells
    Eun Ju Yang, Gyu Hwan Park, Kyung‐Sik Song · 2013 · NeuroToxicology
  22. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice
    Jian Bao, Wei Da Liu, Hongyan Zhou, Yuran Gui, Youhua Yang, Mengjuan Wu, Yifan Xiao, Jinting Shang, Gui-feng Long, Xiji Shu · 2020 · Current Medical Science
  23. The Amazon rain forest plant Uncaria tomentosa (cat’s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles
    Alan D. Snow, Gerardo M. Castillo, Beth P. Nguyen, Paula Y. Choi, Joel A. Cummings, Judy A. Cam, Qubai Hu, Thomas P. Lake, Weihong Pan, Abba J. Kastin et al. · 2019 · Scientific Reports
  24. Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer’s Disease
    Rongzi Li, Yuxian Zhang, Suhail Rasool, Thangiah Geetha, Jeganathan Ramesh Babu · 2019 · Oxidative Medicine and Cellular Longevity
  25. Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease
    Md. Ataur Rahman, MD. Hasanur Rahman, Partha Biswas, Md. Shahadat Hossain, Rokibul Islam, Md. Abdul Hannan, Md Jamal Uddin, Hyewhon Rhim · 2020 · Antioxidants
  26. Lifestyle and health‐related risk factors and risk of cognitive aging among older veterans
    Kristine S. Yaffe, Tina Dan My Hoang, Amy L. Byers, Deborah E. Barnes, Karl E. Friedl · 2014 · Alzheimer s & Dementia
  27. Natural Biomolecules and Protein Aggregation: Emerging Strategies against Amyloidogenesis
    Antonella Sgarbossa · 2012 · International Journal of Molecular Sciences
  28. Botanicals and phytochemicals active on cognitive decline: The clinical evidence
    Arrigo F.G. Cicero, Federica Fogacci, Maciej Banach · 2017 · Pharmacological Research
  29. The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
    Klara Zubčić, Patrick R. Hof, Goran Šimić, Maja Jazvinšćak Jembrek · 2020 · Frontiers in Molecular Neuroscience
  30. Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
    Jiao Li, Min Sun, Xiaodong Cui, Chen Li · 2022 · International Journal of Molecular Sciences
  31. Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective
    Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Zahra Abbasabadi, Nady Braidy, Seyed Mohammad Nabavi · 2018 · Journal of Cellular Physiology
  32. Curcumin-induced upregulation of the anti-tau cochaperone BAG2 in primary rat cortical neurons
    Sachin P. Patil, Nhung T. Tran, Hirosha Geekiyanage, Li Liu, Christina Chan · 2013 · Neuroscience Letters
  33. Epigallocatechin-3-Gallate Attenuates Impairment of Learning and Memory in Chronic Unpredictable Mild Stress-Treated Rats by Restoring Hippocampal Autophagic Flux
    Hong‐Feng Gu, Ya‐Xiong Nie, Qiaozhen Tong, Yaling Tang, Yang Zeng, Kai-Quan Jing, Xi‐Long Zheng, Duan‐Fang Liao · 2014 · PLoS ONE
  34. (−)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer’s disease
    Yufang Guo, Yan Zhao, Ying Nan, Xiang Wang, Yulong Chen, Shuang Wang · 2017 · Neuroreport
  35. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
    Claudia Riccardi, Filomena Napolitano, Daniela Montesarchio, Simone Sampaolo, Mariarosa Anna Beatrice Melone · 2021 · Pharmaceutics
  36. Harnessing neuroplasticity: modern approaches and clinical future
    Andrew Octavian Sasmita, Joshua Kuruvilla, Anna Pick Kiong Ling · 2018 · International Journal of Neuroscience
  37. Inhibition of Aβ aggregates in Alzheimer’s disease by epigallocatechin and epicatechin-3-gallate from green tea
    Tingting Chen, Yanfei Yang, Shajun Zhu, Yapeng Lu, Li Zhu, Yanqing Wang, Xiaoyong Wang · 2020 · Bioorganic Chemistry
  38. Polyphenolic compounds are novel protective agents against lipid membrane damage by α-synuclein aggregates in vitro
    Mario Caruana, Johanna Neuner, Tobias Högen, Felix Schmidt, Frits Kamp, Charles Scerri, Armin Giese, Neville Vassallo · 2012 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  39. Increased BBB permeability contributes to EGCG-caused cognitive function improvement in natural aging rats: pharmacokinetic and distribution analyses
    Binbin Wei, Mingyan Liu, Xin Zhong, Weifan Yao, Minjie Wei · 2019 · Acta Pharmacologica Sinica
  40. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis
    Masahito Yamada, Kenjiro Ono, Tsuyoshi Hamaguchi, Moeko Noguchi‐Shinohara · 2015 · Advances in experimental medicine and biology
  41. Functional Foods: An Approach to Modulate Molecular Mechanisms of Alzheimer’s Disease
    Anna Atlante, Giuseppina Amadoro, Antonella Bobba, Valentina Latina · 2020 · Cells
  42. Optimized Turmeric Extract Reduces ?-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice
    R. Douglas Shytle, Jun Tan, Paula C. Bickford, Kavon P. Rezai-Zadeh, L Hou, Jin Zeng, Paul R. Sanberg · 2012 · Current Alzheimer Research · Retracted
  43. Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus
    Jeng‐Wei Lu, Po‐Shiuan Hsieh, Chang-Chi Lin, Ming‐Kuan Hu, Shih‐Ming Huang, Yuming Wang, Chunyu Liang, Zhiyuan Gong, Yi‐Jung Ho · 2017 · Biochemical and Biophysical Research Communications
  44. Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions
    Ling‐Hsien Tu, Lydia M. Young, Amy G. Wong, Alison E. Ashcroft, Sheena E. Radford, Daniel P. Raleigh · 2014 · Biochemistry
  45. Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?
    Graziamaria Corbi, Valeria Conti, Sergio Davinelli, Giovanni Scapagnini, Amelia Filippelli, Nicola Ferrara · 2016 · Frontiers in Pharmacology
  46. Tea and cognitive health in late life: Current evidence and future directions
    J. Song, Hua Jun Xu, F. Liu, Lei Feng · 2011 · The journal of nutrition health & aging
  47. Epigallocatechin Gallate Reduces Amyloid β‐Induced Neurotoxicity via Inhibiting Endoplasmic Reticulum Stress‐Mediated Apoptosis
    Ke Du, Mingyan Liu, Xin Zhong, Weifan Yao, Qinghuan Xiao, Quan Wen, Bo Yang, Minjie Wei · 2018 · Molecular Nutrition & Food Research
  48. Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress
    Siying Li, Zaoyi Wang, Gang Liu, Meixia Chen · 2024 · Frontiers in Nutrition
  49. Structure–Activity Relationship for (+)-Taxifolin Isolated from Silymarin as an Inhibitor of Amyloid β Aggregation
    Mizuho Sato, Kazuma Murakami, Mayumi UNO, Haruko IKUBO, Yu Nakagawa, Sumie Katayama, Ken‐ichi Akagi, Kazuhiro Irie · 2013 · Bioscience Biotechnology and Biochemistry
  50. Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
    José Teixeira, Tiago Silva, Paula B. Andrade, Fernanda Borges · 2013 · Current Medicinal Chemistry
  51. Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties
    Hatasu Kobayashi, Mariko Murata, Shosuke Kawanishi, Shinji Oikawa · 2020 · International Journal of Molecular Sciences
  52. Novel drug targets based on metallobiology of Alzheimer's disease
    Sanghamitra Bandyopadhyay, Xudong Huang, Debomoy K. Lahiri, Jack T. Rogers · 2010 · Expert Opinion on Therapeutic Targets
  53. Aggregation of Aβ(17–36) in the Presence of Naturally Occurring Phenolic Inhibitors Using Coarse-Grained Simulations
    Yiming Wang, David C. Latshaw, Carol K. Hall · 2017 · Journal of Molecular Biology
  54. Green tea extract enhances parieto-frontal connectivity during working memory processing
    Schmidt, André, Hammann, Felix, Wölnerhanssen, Bettina, Meyer-Gerspach, Anne Christin, Drewe, Jürgen, Beglinger, Christoph, Borgwardt, Stefan · 2014 · Psychopharmacology
  55. Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical
    Scott Darryl Smid, Jesper L.V. Mååg, Ian Musgrave · 2012 · Food & Function
  56. Retrospect and prospect of active principles from Chinese herbs in the treatment of dementia
    Ying Wang, Luqi Huang, Xi-Can Tang, Haiyan Zhang · 2010 · Acta Pharmacologica Sinica
  57. Diabetes and Alzheimer’s Disease: Can Tea Phytochemicals Play a Role in Prevention?
    Warnakulasuriya Mary Ann Dipika Binosha Fernando, Geeshani Somaratne, Kathryn G. Goozee, Shehan Williams, Harjinder Singh, Ralph Nigel Martins · 2017 · Journal of Alzheimer s Disease
  58. Effect of Daily Intake of Green Tea Catechins on Cognitive Function in Middle-Aged and Older Subjects: A Randomized, Placebo-Controlled Study
    Baba, Yoshitake, Inagaki, Shun, Nakagawa, Sae, Kaneko, Toshiyuki, Kobayashi, Makoto, Takihara, Takanobu · 2020 · Molecules
  59. The neuroprotective effects of polyphenols, their role in innate immunity and the interplay with the microbiota
    Giuseppe Annunziata, Antoni Sureda, İlkay Erdoğan Orhan, Maurizio Antonio Battino, Angela Arnone, Manuel Jiménez‐García, Xavier Capó, Joan Cabot, Nima Sanadgol, Francesca Giampieri et al. · 2021 · Neuroscience & Biobehavioral Reviews
  60. Phytochemicals: A Promising Alternative for the Prevention of Alzheimer’s Disease
    Bhupendra Koul, Usma Farooq, Dhananjay Yadav, Minseok Song · 2023 · Life
  61. Identification of Polyphenolic Compounds and Black Tea Extract as Potent Inhibitors of Lipid Membrane Destabilization by Aβ 42 Aggregates
    Alison J. Gauci, Mario Caruana, Armin Giese, Charles Scerri, Neville Vassallo · 2011 · Journal of Alzheimer s Disease
  62. Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer’s β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice
    Jacqueline Hofrichter, Markus Krohn, Toni Schumacher, Cathleen Lange, B Feistel, Bernd Walbroel, Jens Pahnke · 2016 · Journal of Alzheimer s Disease
  63. Targeting Intrinsically Disordered Proteins through Dynamic Interactions
    Jianlin Chen, Xiaorong Liu, Jianhan Chen · 2020 · Biomolecules
  64. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
    Antonio Dominguez‐Meijide, Eftychia Vasili, Annekatrin König, Maria‐Sol Cima‐Omori, Alain Ibáñez de Opakua, Andrei Leonov, Sergey Ryazanov, Markus Zweckstetter, Christian Griesinger, Tiago F. Outeiro · 2020 · Scientific Reports
  65. Epigallocatechin-3-Gallate, a Promising Molecule for Parkinson's Disease?
    Justine Renaud, Seyed Fazel Nabavi, Maria Daglia, Seyed Mohammad Nabavi, Maria‐Grazia Martinoli · 2015 · Rejuvenation Research
  66. Molecular mechanisms of the neuroprotective neurorescue action of multi-target green tea polyphenols
    Silvia A. Mandel · 2012 · Frontiers in Bioscience-Scholar
  67. Chemical Chaperones as Novel Drugs for Parkinson’s Disease
    Jordi Pujols, Samuel Peña‐Díaz, Irantzu Pallarès, Salvador Ventura · 2020 · Trends in Molecular Medicine
  68. Sports-related concussions: diagnosis, complications, and current management strategies
    Jonathan G. Hobbs, Jacob S. Young, Julian E. Bailes · 2016 · Neurosurgical FOCUS
  69. Influence of the Green Tea Leaf Extract on Neurotoxicity of Aluminium Chloride in Rats
    Ankica Jelenković, Marina Jovanović, Ivana D. Stevanović, Nataša Petronijević, Dubravko Bokonjić, Jelena Živković, Rajko P. Igic · 2013 · Phytotherapy Research
  70. Yuzu Extract Prevents Cognitive Decline and Impaired Glucose Homeostasis in β-Amyloid–Infused Rats1–3
    Hye Jeong Yang, Jin Taek Hwang, Dae Young Kwon, Min Jung Kim, Suna Kang, Na Rang Moon, Sunmin Park · 2013 · Journal of Nutrition
  71. Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer’s Disease
    Claire Alexander, Ali Parsaee, Maryam Vasefi · 2023 · Biology
  72. (−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus
    Ning Jia, Kun Soo Han, Jingjing Kong, Xiumei Zhang, Sha Sha, Gui-Ru Ren, Yunpeng Cao · 2013 · Molecular and Cellular Biochemistry
  73. Does Green Tea Induce Hormesis?
    Edward J. Calabrese, Aristidis Michael Tsatsakis, Evgenios Agathokleous, James Giordano, Vittorio Calabrese · 2020 · Dose-Response
  74. Effects and Mechanisms of Tea on Parkinson’s Disease, Alzheimer’s Disease and Depression
    Min Luo, Ren‐You Gan, Bangyan Li, Qianqian Mao, Ao Shang, Xiaoyu Xu, Hangyu Li, Hua-Bin Li · 2021 · Food Reviews International
  75. Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging
    Hilda Martínez‐Coria, Isabel Arrieta‐Cruz, Roger Gutiérrez Juárez, Héctor Eduardo López-Valdés · 2023 · International Journal of Molecular Sciences
  76. Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives
    Muhammad Ayaz, Osama F. Mosa, Asif Nawaz, Alashary Adam Eisa Hamdoon, Modawy Elnour Modawy Elkhalifa, Abdul Sadiq, Farhat Ullah, Alshebli Ahmed, Atul Kabra, Haroon Zaman Khan et al. · 2023 · Phytomedicine
  77. Targeting NADPH Oxidase and Phospholipases A2 in Alzheimer’s Disease
    Ágnes Simonyi, Yan He, Wenwen Sheng, Albert Y. Sun, W. Gibson Wood, Gary A. Weisman, Grace Y. Sun · 2010 · Molecular Neurobiology
  78. Effects of supplementation with green tea catechins on plasma C-reactive protein concentrations: A systematic review and meta-analysis of randomized controlled trials
    Maria-Corina Șerban, Amirhossein Sahebkar, Diana Antal, Sorin Ursoniu, Maciej Banach · 2015 · Nutrition
  79. Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome
    Silvina Catuara‐Solarz, Jose Espinosa‐Carrasco, Ionas Erb, Klaus Langohr, Cédric Notredame, Juan R. González, Mara Dierssen · 2015 · Frontiers in Behavioral Neuroscience
  80. HP-β-cyclodextrin as an inhibitor of amyloid-β aggregation and toxicity
    Baiping Ren, Binbo Jiang, Rundong Hu, Mingzhen Zhang, Hong Chen, Jie Ma, Yan Ping Sun, Lingyun Jia, Jie Zheng · 2016 · Physical Chemistry Chemical Physics
  81. Molecular mechanisms of amyloid disaggregation
    Kimberly Jia Yi Low, Anandalakshmi Venkatraman, Jodhbir Singh Mehta, Konstantin V. Pervushin · 2021 · Journal of Advanced Research
  82. Nanotherapeutics for Alzheimer’s disease (AD): Past, present and future
    Mohammad Fazil, Shadab, Sanjula Baboota, Jasjeet Kaur Sahni, Javed Ali · 2011 · Journal of drug targeting
  83. Catechins and Procyanidins of Ginkgo biloba Show Potent Activities towards the Inhibition of β-Amyloid Peptide Aggregation and Destabilization of Preformed Fibrils
    Haiyan Xie, Jingrong Wang, Lee‐Fong Yau, Yong Liu, Liang Liu, Quan‐Bin Han, Zhongzhen Zhao, Zhi‐Hong Jiang · 2014 · Molecules
  84. Thermodynamic Analysis of the Molecular Interactions between Amyloid β-Protein Fragments and (−)-Epigallocatechin-3-gallate
    Shihui Wang, Xiaoyan Dong, Yan Ping Sun · 2012 · The Journal of Physical Chemistry B
  85. Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go
    Pragya Prasanna, Arun Upadhyay · 2021 · ACS Pharmacology & Translational Science
  86. Neuro-Nutrition and Exercise Synergy: Exploring the Bioengineering of Cognitive Enhancement and Mental Health Optimization
    Vicente Javier Clemente‐Suárez, Alexandra Martín-Rodríguez, Agustín Curiel-Regueros, Alejandro Rubio-Zarapuz, José Francisco Tornero-Aguilera · 2025 · Bioengineering
  87. Tea Consumption and Cognitive Impairment: A Cross-Sectional Study among Chinese Elderly
    Wei Shen, Yuanyuan Xiao, Xuhua Ying, Songtao Li, Yujia Zhai, Xiaopeng Shang, Fudong Li, Xiyi Wang, Fan He, Junfen Lin · 2015 · PLoS ONE
  88. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
    Matthew J. Sharman, Erika Gyengési, Huazheng Liang, Pratishtha Chatterjee, Tim Karl, Qiao-Xin Li, Markus Rene Wenk, Barry B. Halliwell, Ralph Nigel Martins, Gerald W Münch · 2019 · Neurobiology of Disease
  89. Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer’s Disease: A Systematic Review
    Reinhard Gruendler, Berit Hippe, Vesna Šendula Jengić, Borut Peterlin, Alexander G. Haslberger · 2020 · Molecules
  90. Negatively charged hydrophobic nanoparticles inhibit amyloid β-protein fibrillation: The presence of an optimal charge density
    Hongchen Liu, Baolong Xie, Xiaoyan Dong, Lei Zhang, Yongjian Wang, Fufeng Liu, Yan Ping Sun · 2016 · Reactive and Functional Polymers
  91. Molecular determinants of the interaction of EGCG with ordered and disordered proteins
    Giuliana Fusco, Máximo Sanz-Hernández, Francesco Simone Ruggeri, Michele Vendruscolo, Christopher Martin Dobson, Alfonso De Simone · 2018 · Biopolymers
  92. Potential of flavonoids as anti-Alzheimer’s agents: bench to bedside
    Rajwinder Kaur, Ankita Sood, Damanpreet Kaur Lang, Saurabh Bhatia, Ahmed Al‐Harrasi, Lotfi Aleya, Tapan Behl · 2022 · Environmental Science and Pollution Research
  93. Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
    Leonidas Chouliaras, Annerieke S. R. Sierksma, Günter Kenis, Jos Prickaerts, Marijke A.M. Lemmens, Ivona Brasnjevic, Eva L. van Donkelaar, Pilar Martínez‐Martínez, Mario H. Losen, Marc H. De Baets et al. · 2010 · International Journal of Alzheimer s Disease
  94. Neural effects of green tea extract on dorsolateral prefrontal cortex
    Borgwardt, S, Hammann, F, Scheffler, K, Kreuter, M, Drewe, J, Beglinger, C · 2012 · European Journal of Clinical Nutrition
  95. Synergistic effects of negatively charged hydrophobic nanoparticles and (−)-epigallocatechin-3-gallate on inhibiting amyloid β-protein aggregation
    Hongchen Liu, Linling Yu, Xiaoyan Dong, Yan Ping Sun · 2016 · Journal of Colloid and Interface Science
  96. Alpha-Linolenic Acid fromPerilla frutescensvar.japonicaOil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation
    Ah Young Lee, Myoung Hee Lee, Sanghyun Lee, Eun Ju Cho · 2017 · Journal of Agricultural and Food Chemistry
  97. Optimization of Informative Spectral Variables for the Quantification of EGCG in Green Tea Using Fourier Transform Near-Infrared (FT-NIR) Spectroscopy and Multivariate Calibration
    Zhiming Guo, Quansheng Chen, Liping Chen, Wenqian Huang, Chi Zhang, Chunjiang Zhao · 2011 · Applied Spectroscopy
  98. Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer’s disease
    Darrell R. Sawmiller, Song Li, Takashi Mori, Ahsan Habib, David Rongo, Vedad Delic, Patrick C. Bradshaw, R. Douglas Shytle, Cyndy Davis Sanberg, Paula C. Bickford et al. · 2017 · Heliyon
  99. Biological Evaluation and Docking Analysis of Potent BACE1 Inhibitors from Boesenbergia rotunda
    Kumju Youn, Mira Jun · 2019 · Nutrients
  100. Kinetics theories to understand the mechanism of aggregation of a protein and to design strategies for its inhibition
    Shilpa Sharma, Priya Modi, Gargi Sharma, Shashank Deep · 2021 · Biophysical Chemistry